Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
Since 2015, the cancer treatment lenvatinib has been used for patients with advanced radioactive iodine- (RAI-) refractory thyroid differentiated cancer; however, the drug’s long-term effects have not been fully investigated. We report three cases in which lenvatinib treatment initially improved the...
Saved in:
| Main Authors: | Hiroyuki Iwasaki, Soji Toda, Daisuke Murayama, Hiroyuki Takahashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2020/6667237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
by: Haruhiko Yamazaki, et al.
Published: (2023-03-01) -
Occult Thyroid Carcinoma without Malignant Thyroid Gland Findings during Preoperative Examination: Report of Three Cases
by: Soji Toda, et al.
Published: (2020-01-01) -
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study
by: Soji Toda, et al.
Published: (2024-01-01) -
Be(a)ware of Leukocytosis in Papillary Thyroid Cancer
by: Styliani Laskou, et al.
Published: (2022-01-01) -
LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)